Reshape Lifesciences Q2 EPS $(0.06) Up From $(1.08) YoY, Sales $1.97M Miss $2.21M Estimate
Author: Benzinga Newsdesk | August 14, 2024 04:11pm
Reshape Lifesciences (NASDAQ:
RSLS) reported quarterly losses of $(0.06) per share. This is a 94.44 percent increase over losses of $(1.08) per share from the same period last year. The company reported quarterly sales of $1.97 million which missed the analyst consensus estimate of $2.21 million by 11.09 percent. This is a 12.82 percent decrease over sales of $2.25 million the same period last year.
Posted In: RSLS